Home Privacy Archive Realtime Report

Stock Trading History of Glassman Daniel

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Glassman Daniel since year 2005. The trader's CIK number is 902023. At the time of this reporting, Glassman Daniel is the Pres. & CEO of Bradley Pharmaceuticals Inc (stock ticker symbol NYSE: BDY).

Stock purchases, sales, and option exercises reported by *Glassman Daniel* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2007-03-20	NYSE: BDY	Bradley Pharmaceuticals Inc	Option Exercise	315,000	13.13	4,134,690

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Glassman Daniel (Pres. & CEO of Bradley Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.